Pharmather Holdings Stock Performance
| PHRRF Stock | USD 0.16 0.01 5.88% |
The company holds a Beta of 0.83, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pharmather Holdings' returns are expected to increase less than the market. However, during the bear market, the loss of holding Pharmather Holdings is expected to be smaller as well. At this point, Pharmather Holdings has a negative expected return of -0.0561%. Please make sure to check Pharmather Holdings' total risk alpha, as well as the relationship between the skewness and day median price , to decide if Pharmather Holdings performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Pharmather Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Pharmather Holdings is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 2.8 M |
Pharmather |
Pharmather Holdings Relative Risk vs. Return Landscape
If you would invest 19.00 in Pharmather Holdings on September 17, 2024 and sell it today you would lose (3.00) from holding Pharmather Holdings or give up 15.79% of portfolio value over 90 days. Pharmather Holdings is currently producing negative expected returns and takes up 6.53% volatility of returns over 90 trading days. Put another way, 58% of traded otc stocks are less volatile than Pharmather, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Pharmather Holdings Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharmather Holdings' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Pharmather Holdings, and traders can use it to determine the average amount a Pharmather Holdings' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0086
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PHRRF |
Estimated Market Risk
| 6.53 actual daily | 58 58% of assets are less volatile |
Expected Return
| -0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pharmather Holdings is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pharmather Holdings by adding Pharmather Holdings to a well-diversified portfolio.
Pharmather Holdings Fundamentals Growth
Pharmather OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Pharmather Holdings, and Pharmather Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pharmather OTC Stock performance.
| Return On Equity | -0.63 | |||
| Return On Asset | -0.25 | |||
| Current Valuation | (3.24 M) | |||
| Shares Outstanding | 88.17 M | |||
| Price To Earning | 2.26 X | |||
| Price To Book | 0.57 X | |||
| EBITDA | (4.1 M) | |||
| Cash And Equivalents | 10.15 M | |||
| Cash Per Share | 0.12 X | |||
| Book Value Per Share | 0.09 X | |||
| Cash Flow From Operations | (3.51 M) | |||
| Earnings Per Share | (0.04) X | |||
| Total Asset | 12.16 M | |||
About Pharmather Holdings Performance
By analyzing Pharmather Holdings' fundamental ratios, stakeholders can gain valuable insights into Pharmather Holdings' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Pharmather Holdings has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pharmather Holdings has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
PharmaTher Holdings Ltd., a clinical-stage psychedelics biotech company, focuses on the research, development, and commercialization of novel uses, formulations, and delivery methods of psychedelics to treat mental illness, neurological, and pain disorders. The company was incorporated in 2019 and is headquartered in Toronto, Canada. Pharmather Hldgs is traded on OTC Exchange in the United States.Things to note about Pharmather Holdings performance evaluation
Checking the ongoing alerts about Pharmather Holdings for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Pharmather Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pharmather Holdings generated a negative expected return over the last 90 days | |
| Pharmather Holdings has high historical volatility and very poor performance | |
| Pharmather Holdings has some characteristics of a very speculative penny stock | |
| Pharmather Holdings has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (4.01 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Pharmather Holdings has accumulated about 10.15 M in cash with (3.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Roughly 19.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Fmr LLC Sells 220,929 Shares of GH Research PLC - MarketBeat |
- Analyzing Pharmather Holdings' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pharmather Holdings' stock is overvalued or undervalued compared to its peers.
- Examining Pharmather Holdings' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pharmather Holdings' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pharmather Holdings' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Pharmather Holdings' otc stock. These opinions can provide insight into Pharmather Holdings' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Pharmather OTC Stock analysis
When running Pharmather Holdings' price analysis, check to measure Pharmather Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmather Holdings is operating at the current time. Most of Pharmather Holdings' value examination focuses on studying past and present price action to predict the probability of Pharmather Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmather Holdings' price. Additionally, you may evaluate how the addition of Pharmather Holdings to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |